Lexeo Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Lexeo Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Lexeo Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lexeo Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $95k | 14k | 6.64 |
| 2025-03-31 | $48k | 14k | 3.47 |
| 2024-12-31 | $88k | 13k | 6.58 |
| 2024-09-30 | $93k | 10k | 9.04 |
| 2024-06-30 | $70k | 4.4k | 16.04 |
| 2024-03-31 | $93k | 6.0k | 15.68 |
| 2023-12-31 | $1.5k | 112 | 13.42 |